Objective monitoring of neuromuscular block should become the standard of care

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 6, 2009, Pages 837-

  El Orbany, M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; ROCURONIUM;

DRUG MONITORING; ELECTROCARDIOGRAPHY; LETTER; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL;

ANDROSTANOLS; ANTI-INFLAMMATORY AGENTS; DRUG INTERACTIONS; HUMANS; MONITORING, PHYSIOLOGIC; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PREDNISOLONE;

EID: 67149146307     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.01997.x     Document Type: Letter

References (4)

1. Soltész S, Mencke T, Stunz M, Diefenbach C, Ziegeler S, Molter GP. Attenuation of a rocuroium-induced neuromuscular block in patients receiving prednisolone. Acta Anaesthesiol Scand 2009 53 : 443 8.
2. Eikermann M, Rasmussen LS. Improving the prediction of neuromuscular block. Acta Anaesthesiol Scand 2009 53 : 423 4.
3. Kopman A. Neuromuscular monitoring: old issues, new controversies. J Crit Care 2009 24 : 11 20.
4. Eriksson LI. Evidence-based practice and neuromuscular monitoring. It is time for routine quantitative assessment. Anesthesiology 2003 98 : 1037 9.